JADE BIOSCIENCES INC (JBIO) Stock Balance Sheet
NASDAQ:JBIO - Nasdaq - US0080641071 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 22.40M | 54.20M | |||
| Cash Equivalents | 44.22M | 33.75M | 23.49M | N/A | N/A | |||
| Marketable Securities | 31.99M | 44.87M | 98.95M | 106.80M | 113.20M | |||
| Other Current Assets | 1.16M | 1.49M | 1.79M | 2.30M | 7.00M | |||
| Total Current Assets | 77.37M | 80.12M | 124.23M | 131.50M | 174.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 160.00K | 215.00K | 902.00K | 1.20M | 700.00K | |||
| Other Non-Current Assets | N/A | 0.00 | 2.28M | 2.60M | 300.00K | |||
| Total Non-Current Assets | 160.00K | 215.00K | 3.19M | 3.80M | 1.10M | |||
| TOTAL ASSETS | 77.53M | 80.33M | 127.42M | 135.30M | 175.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.92M | 3.29M | 14.07M | 4.80M | 1.20M | |||
| Accounts Payable | 69.00K | 224.00K | 2.40M | 2.60M | 1.20M | |||
| Other Current Liabilities | 429.00K | 319.00K | 1.17M | 400.00K | 100.00K | |||
| Total Current Liabilities | 2.42M | 3.83M | 17.64M | 7.80M | 2.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 70.00K | 70.00K | 325.00K | 800.00K | 400.00K | |||
| Total Non-Current Liabilities | 70.00K | 70.00K | 325.00K | 800.00K | 300.00K | |||
| TOTAL LIABILITIES | 2.49M | 3.90M | 17.96M | 8.60M | 2.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -235.57M | -233.05M | -163.42M | -87.90M | -36.40M | |||
| Additional Paid In Capital | 310.56M | 309.38M | 272.64M | 215.10M | 208.90M | |||
| Common Shares | 3.00K | 3.00K | 3.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 50.00K | 105.00K | 237.00K | -500.00K | -100.00K | |||
| Shares Outstanding | 828.10K | 828.10K | 793.20K | 706.30K | 697.40K | |||
| Tangible Book Value per Share | 90.62 | 92.30 | 138.00 | 5.13 | 7.07 | |||
| Total Shareholders' Equity | 75.05M | 76.43M | 109.46M | 126.70M | 172.40M | |||
| TOTAL LIABILITIES AND EQUITY | 77.53M | 80.33M | 127.42M | 135.30M | 175.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 32.01 | 20.93 | 7.04 | 16.86 | 67.04 | |||
| Return On Assets (ROA) | -63.15% | -86.68% | -59.27% | -38.07% | -13.11% | |||
| Return On Equity (ROE) | -65.24% | -91.10% | -69.00% | -40.66% | -13.34% | |||
All data in USD , ROIC based on taxRate of 0.21